ArticleBMC surgery2026
Minimally invasive internal fixation of Sanders IV calcaneal fractures using a tarsal sinus plate and cannulated screws.
Article in BMC surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
objectivesThis study aimed to assess the clinical efficacy of combining tarsal sinus plates with cannulated screw-based minimally invasive internal fixation for the management of Sanders type IV calcaneal fractures.
methodsBetween January 2019 and July 2023, we conducted a retrospective analysis of 32 cases involving Sanders type IV calcaneal fractures treated by our medical team. The treatment approach involved the utilization of tarsal sinus plates in conjunction with minimally invasive internal fixation using cannulated screws. Among the cases analyzed, there were 16 males and 16 females, with an average age of 34.5 years (ranging from 21 to 50 years). We observed and recorded key parameters, including operative duration, intraoperative blood loss, postoperative complications, preoperative and immediate postoperative calcaneal width, calcaneal Bohler angle, and Gissane angle. Additionally, we conducted a review and documented the healing progress six months postoperatively. Pain levels were assessed using the visual analogue scale (VAS) before the procedure and at the final follow-up, while foot function was evaluated using the AOFAS (American Orthopaedic Foot and Ankle Society) Ankle Hindfoot Scale.
resultsThe mean operative time for the 32 patients was 100.5 min (ranging from 62 to 144 min), with an average blood loss of 80 ml (ranging from 61 to 110 ml). Importantly, all fractures achieved union, with a 100% success rate, and no adverse complications were recorded. Postoperative X-ray imaging revealed statistically significant improvements in calcaneal width, Bohler angle, and Gissane angle compared to preoperative measurements (P < 0.05). All patients were subject to follow-up assessments, with the average follow-up duration being 18 months (ranging from 12 to 24 months). At the final follow-up, patients reported a notably lower VAS pain score of 1.3 ± 0.2 points, a statistically significant reduction (P < 0.05) when compared to preoperative values. Furthermore, the average AOFAS score at this stage was 84.4 ± 6.3 points, also demonstrating a statistically significant improvement compared to preoperative scores (P < 0.05).
conclusionCombining tarsal sinus plates with cannulated screw-based minimally invasive internal fixation is an effective treatment modality for Sanders type IV calcaneal fractures. This approach offers several advantages, including minimal trauma, a low risk of postoperative infection, reduced likelihood of soft tissue necrosis in the skin flap, superior fracture reduction and fixation, expedited functional recovery, and a reduced incidence of postoperative complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.